NeuraLight has launched from stealth with $5.5 million in seed funding to apply AI to advance drug development for neurological disorders. The company was co-founded by Micha Breakstone, the co-founder and former president of Chorus.ai, which sold to ZoomInfo for $575 million earlier this year. Breakstone now leads NeuraLight as the company’s CEO alongside co-founder […]
Get the latest industry news first when you subscribe to our daily newsletter.
We will never sell or share your information without your consent. See our privacy policy.